Free Trial

Rayonier (RYN) Competitors

Rayonier logo
$24.12 +0.33 (+1.37%)
Closing price 06/10/2025 03:59 PM Eastern
Extended Trading
$24.12 +0.01 (+0.04%)
As of 06/10/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RYN vs. OHI, CUBE, RHP, HR, EPR, SBRA, GEO, NHI, PCH, and MPW

Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Health Care REIT (SBRA), The GEO Group (GEO), National Health Investors (NHI), PotlatchDeltic (PCH), and Medical Properties Trust (MPW). These companies are all part of the "specialized reits" industry.

Rayonier vs.

Rayonier (NYSE:RYN) and Omega Healthcare Investors (NYSE:OHI) are both construction companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation, community ranking and profitability.

89.1% of Rayonier shares are held by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are held by institutional investors. 0.9% of Rayonier shares are held by company insiders. Comparatively, 1.4% of Omega Healthcare Investors shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Rayonier has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500. Comparatively, Omega Healthcare Investors has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500.

Rayonier presently has a consensus price target of $27.75, suggesting a potential upside of 15.07%. Omega Healthcare Investors has a consensus price target of $41.88, suggesting a potential upside of 13.93%. Given Rayonier's higher possible upside, equities research analysts plainly believe Rayonier is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rayonier
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25
Omega Healthcare Investors
0 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

Omega Healthcare Investors has a net margin of 38.65% compared to Rayonier's net margin of 28.44%. Omega Healthcare Investors' return on equity of 9.71% beat Rayonier's return on equity.

Company Net Margins Return on Equity Return on Assets
Rayonier28.44% 3.86% 1.99%
Omega Healthcare Investors 38.65%9.71%4.35%

In the previous week, Omega Healthcare Investors had 4 more articles in the media than Rayonier. MarketBeat recorded 8 mentions for Omega Healthcare Investors and 4 mentions for Rayonier. Omega Healthcare Investors' average media sentiment score of 0.94 beat Rayonier's score of 0.01 indicating that Omega Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rayonier
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Omega Healthcare Investors
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Rayonier pays an annual dividend of $1.09 per share and has a dividend yield of 4.5%. Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.3%. Rayonier pays out 46.8% of its earnings in the form of a dividend. Omega Healthcare Investors pays out 166.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Omega Healthcare Investors received 142 more outperform votes than Rayonier when rated by MarketBeat users. Likewise, 57.62% of users gave Omega Healthcare Investors an outperform vote while only 54.00% of users gave Rayonier an outperform vote.

CompanyUnderperformOutperform
RayonierOutperform Votes
304
54.00%
Underperform Votes
259
46.00%
Omega Healthcare InvestorsOutperform Votes
446
57.62%
Underperform Votes
328
42.38%

Omega Healthcare Investors has lower revenue, but higher earnings than Rayonier. Rayonier is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rayonier$1.23B3.05$359.10M$2.3310.35
Omega Healthcare Investors$1.08B9.80$406.33M$1.6122.83

Summary

Omega Healthcare Investors beats Rayonier on 14 of the 20 factors compared between the two stocks.

Get Rayonier News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYN vs. The Competition

MetricRayonierReal estate investment trusts IndustryConstruction SectorNYSE Exchange
Market Cap$3.76B$7.09B$8.73B$19.81B
Dividend Yield4.65%6.84%2.04%3.85%
P/E Ratio10.2264.5816.9735.71
Price / Sales3.058.62101.5345.94
Price / Cash18.5417.3221.7617.52
Price / Book2.021.715.034.84
Net Income$359.10M$177.71M$553.80M$1.02B
7 Day Performance3.31%2.31%2.16%2.35%
1 Month Performance2.53%3.27%4.46%5.86%
1 Year Performance-19.96%6.35%94.13%14.72%

Rayonier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYN
Rayonier
4.3451 of 5 stars
$24.12
+1.4%
$27.75
+15.1%
-20.0%$3.76B$1.23B10.22420
OHI
Omega Healthcare Investors
3.9934 of 5 stars
$36.77
-1.8%
$41.88
+13.9%
+15.5%$10.64B$1.08B23.7250
CUBE
CubeSmart
2.6284 of 5 stars
$43.28
+0.0%
$47.36
+9.4%
+2.6%$9.87B$1.08B24.452,800Positive News
RHP
Ryman Hospitality Properties
4.0747 of 5 stars
$98.10
+1.4%
$112.00
+14.2%
+0.2%$5.89B$2.40B22.351,270Positive News
Insider Trade
HR
Healthcare Realty Trust
3.6776 of 5 stars
$14.51
+0.4%
$16.80
+15.8%
-10.8%$5.10B$1.22B-8.15580Positive News
EPR
EPR Properties
3.7205 of 5 stars
$56.88
+0.5%
$54.57
-4.1%
+41.6%$4.33B$649.20M24.6260
SBRA
Sabra Health Care REIT
1.2355 of 5 stars
$17.79
-0.3%
$19.50
+9.6%
+28.1%$4.23B$720.03M33.5740Positive News
GEO
The GEO Group
3.7245 of 5 stars
$27.02
+0.2%
$38.00
+40.7%
+96.8%$3.82B$2.42B93.1615,800Trending News
NHI
National Health Investors
3.5933 of 5 stars
$71.75
-1.0%
$85.75
+19.5%
+11.4%$3.35B$342.96M24.6620Positive News
Analyst Forecast
PCH
PotlatchDeltic
3.8329 of 5 stars
$39.20
+1.4%
$48.57
+23.9%
-2.3%$3.08B$1.10B140.001,330
MPW
Medical Properties Trust
3.5357 of 5 stars
$4.52
-0.6%
$5.75
+27.4%
-8.5%$2.71B$948.03M-1.07120Positive News

Related Companies and Tools


This page (NYSE:RYN) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners